NMT’s products are designed to treat medical conditions on par with leading medications in terms of clinical efficacy, safety, patient morbidity, and ease of use. In fact, NMT’s devices go beyond traditional pharmaceutical products by allowing patients complete control over the administration of their therapy and the immediate relief of their symptoms.

The NMT core products are protected by a comprehensive and extensive patent portfolio comprised of numerous patents worldwide covering product class, technology, method and generational devices, brand protection in a number of key registered trademarks, and multiple FDA approvals.

In addition, NMT has numerous pending patent applications, considerable proprietary software, manufacturing, registered designs, design rights, and trade secrets associated with its core technology that supplements the current IP platform. All of these assets significantly enhance the competitive advantage of NMT and will enable us to be in the forefront in the development of nerve stimulation medical devices.